Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-08-21

Clinical Trial Results: First in Human Study of TLC-ART 101 (ACTU 2001) [Phase 1]

View source ↗

Summary

First-in-human Phase 1 study of TLC-ART 101 (ACTU 2001) completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TLC-ART 101

Snippet

Sponsor: University of Washington | Conditions: Human Immunodeficiency Virus, Treatment | Phase 1 | Status: COMPLETED | Results posted: 2026-08-21